 - To evaluate the effects of oral HDV-I versus placebo on the 7-point glucose test, fasting plasma glucose FPG, insulin, homeostasis model assessment of insulin resistance HOMA-IR, homeostasis model assessment of β-cell function HOMA-β, frequency of hypoglycemic events, body weight, and lipid levels; and 